Loneliness and cognitive dysfunction in elderly cancer patients

Ali Alkan(Muğla University), Filiz Çay Şenler, Arzu Yaşar(Ankara University), Murat Varlı(Ankara University), Yüksel Ürün(Ankara University), Hande Selvi Öztorun(Ankara University), Gülseren Tuncay(Adıyaman University), Sevgi Aras(Istanbul Medipol University), Esat Çınar(Ankara University), Ebru Karcı(Ankara University)

Annals of Oncology

September 1, 2017

10.1093/annonc/mdx384.001

Cited by 0

Related Papers

Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer

|New England Journal of Medicine|2018|3.7k

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

|The Lancet|2019|3.4k

Phase 3 study of carboplatin-paclitaxel/nab-paclitaxel (Chemo) with or without pembrolizumab (Pembro) for patients (Pts) with metastatic squamous (Sq) non-small cell lung cancer (NSCLC).

|Journal of Clinical Oncology|2018|121

The role of Frailty on Adverse Outcomes Among Older Patients with COVID-19

|Journal of Infection|2020|111

Oxidative stress and antioxidant status in elderly diabetes mellitus and glucose intolerance patients

|Archives of Gerontology and Geriatrics|2004|77